Distinct invasive patterns in situ between estrogen receptor‐positive and triple‐negative breast cancer through the intraductal tracking of carbon nanoparticles
International Journal of Cancer · 2023
DOI: 10.1002/ijc.34611 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Xinwen Kuang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Nanoparticles, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Beijing Xisike Clinical Oncology Research Foundation, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Given that the transition from ductal carcinoma in situ (DCIS) to invasive breast cancer (BC) is crucial during the BC progression, the mechanism involved in the invasion transition behind triple‐negative breast cancer (TNBC) and estrogen receptor‐positive (ER‐positive) subtype has remained elusive. This article detected distinct invasion patterns of BC cells between the ER‐positive and TNBC using intraductal murine models with intraductal administration of carbon nanoparticles (CNPs). First, the feasibility of the utility of CNPs as a tracer was proved. The area ratio of CNPs and tumor cells invading the stroma at the late stage was found significantly higher than that in the early stage in MNU‐induced ER‐positive BC. However, opposite results were obtained in the triple‐negative model. Consequently, we proposed that the ER‐positive phenotype cells behave differently between different stages during tumor progression while there is no such difference in the invasion process of TNBC cells. The analysis regarding the duct integrity along with immunohistochemical characteristics further explained the distinct invasion features between the ER‐positive and triple‐negative subtypes. Last, the relationship between the duct thickness and the duct integrity suggested that ER‐positive tumors gradually increased in size within the lumen before the invasion. Overall, this study suggested the different invasion characteristics of ER‐positive BC and TNBC in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
- Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, People's Republic of China.
- Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing, People's Republic of China.
- Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China.
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
- Department of Breast Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.
ORCID-Profile: Xinwen Kuang, Shengrong Sun
Förderung
- Beijing Xisike Clinical Oncology Research Foundation
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Science and Technology Major Project of Hubei Province
Zitieren
APA
Kuang, X., Luo, Z., Sun, Z., Hu, J., Liu, J., Kong, D., Wang, G., Guo, L., Luo, L., Zheng, W., Sun, S., Rao, Y., & Chen, C. (2023). Distinct invasive patterns in situ between estrogen receptor‐positive and triple‐negative breast cancer through the intraductal tracking of carbon nanoparticles. International Journal of Cancer. https://doi.org/10.1002/ijc.34611
Vancouver
Kuang X, Luo Z, Sun Z, Hu J, Liu J, Kong D, et al. Distinct invasive patterns in situ between estrogen receptor‐positive and triple‐negative breast cancer through the intraductal tracking of carbon nanoparticles. International Journal of Cancer. 2023. doi:10.1002/ijc.34611
BibTeX
@article{Kuang2023,
author = {Kuang, Xinwen and Luo, Zixuan and Sun, Zhihong and Hu, Jiawei and Liu, Jianhua and Kong, Deguang and Wang, Guannan and Guo, Liantao and Luo, Lan and Zheng, Weijie and Sun, Shengrong and Rao, Yan and Chen, Chuang},
title = {Distinct invasive patterns in situ between estrogen receptor‐positive and triple‐negative breast cancer through the intraductal tracking of carbon nanoparticles},
journal = {International Journal of Cancer},
year = {2023},
doi = {10.1002/ijc.34611}
}
EUVIMED